세계의 환자 체온 모니터링 시장 : 제품별, 부위별, 용도별, 최종 사용자별, 지역별 예측(-2032년)

The global patient temperature monitoring market is projected to reach USD 3.85 billion by 2032 from USD 2.44 billion in 2025, at a CAGR of 6.7% during the forecast period.

The growth of the market can be attributed to the escalating incidence of infectious diseases and chronic conditions that necessitate ongoing monitoring of vital signs. A key factor driving this trend is the heightened emphasis on early detection and proactive management of health issues, particularly among the elderly, for whom temperature is a critical clinical marker. Additionally, the increase in surgical interventions, coupled with rising hospital admissions and a pronounced focus on post-operative recovery, is amplifying the demand for precise and continuous temperature monitoring solutions. However, the market faces challenges due to the limited accuracy and reliability of available technologies, including infrared sensors and traditional mercury thermometers.

"In 2024, the handheld temperature monitoring devices segment accounted for the largest share of the patient temperature monitoring market."

On the basis of products, the patient temperature monitoring market is segmented into wearable continuous monitoring sensors, tabletop temperature monitoring devices, smart temperature monitoring patches, handheld temperature monitoring devices, and invasive temperature monitoring devices. In 2024, the handheld temperature monitoring devices segment dominated the patient temperature monitoring market, primarily due to their extensive application across diverse healthcare environments, such as hospitals, clinics, and home care settings. These devices are preferred for their portability, user-friendly design, rapid readings, and cost-efficiency, solidifying their role as standard instruments for both routine clinical assessments and personal monitoring. Furthermore, the handheld temperature monitoring devices segment is categorized into mercury, digital, and infrared thermometers. Notably, the digital thermometers segment captured the largest share of the market in 2024, driven by advancements in technology and increased accuracy.

"Hospitals segment commanded the largest share of the patient temperature monitoring market in 2024."

On the basis of end users, the patient temperature monitoring market is segmented into hospitals, hospitals, home care settings, ambulatory care centers, and other end users. In 2024, the hospitals segment is projected to hold the largest share of the patient temperature monitoring market. This segment encompasses critical areas such as operating rooms, emergency departments, and intensive care units (ICUs). The substantial market share is primarily driven by the escalating prevalence of diverse diseases and conditions that necessitate hospitalization. As patient volumes rise and the frequency of surgical interventions increases, the demand for sophisticated temperature monitoring systems in hospitals is expected to expand correspondingly during the forecast period. As reported by the American Hospital Association (AHA) in 2022, there are currently 6,093 hospitals in the United States. Furthermore, heightened investments in healthcare infrastructure and the integration of advanced monitoring technologies are anticipated to further propel growth within this segment.

"Europe accounted for the second-largest share of the patient temperature monitoring market, by region, in 2024."

The global patient temperature monitoring market is delineated into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, Europe stands as the second-largest regional market for patient temperature monitoring, driven by key players such as Germany, the UK, and France, which together constitute a substantial share of regional demand. The region has witnessed a marked uptick in the adoption of remote patient monitoring technologies, largely in response to the increasing necessity for efficient, non-invasive temperature assessment methodologies. In particular, Germany is forecasted to command the largest segment of the European patient temperature monitoring market in 2024. According to projections from the UN Population Division, the demographic cohort aged 65 and over in Germany is anticipated to surge by 41%, reaching approximately 24 million by 2050-representing around 30% of the country's overall population. Furthermore, as reported by the Financial Times, over half of Germany's population will be aged 48 and above by 2050, with nearly one-third surpassing the age of 60. This demographic shift is likely to escalate the demand for spinal, orthopedic, and cardiovascular interventions, thereby necessitating advanced continuous patient monitoring solutions, including sophisticated patient temperature monitoring devices.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1- 40%, Tier 2- 30%, and Tier 3- 30%
• By Designation: C Level- 27%, Director Level- 18% and Others- 55%
• By Region: North America- 35%, Europe- 30%, Asia Pacific- 22%, Latin America- 10%, and Middle East & Africa- 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the patient temperature monitoring market are Koninklijke Philips N.V. (Netherlands), Cardinal Health (US), Baxter (Hill-Rom Holdings, Inc.) (US), Dragerwerk AG & Co. KGaA (Germany), Becton, Dickinson and Company (US), Omron Healthcare, Inc. (Japan), Masimo (US), Helen of Troy (US), Solventum (US), Terumo Corporation (Japan), DONGGUAN ACTHERM MEDICAL CORP.(China), Hicks India (India), Microlife Corporation (Taiwan), Medtronic (Ireland), American Diagnostic Corporation (US), EASYTEM (South Korea), THERMOMEDICS, INC. (US), Cosinuss GmbH (Germany), A&D Company, Limited (US), Paul Hartmann AG (Germany), Geratherm Medical AG (Germany), Exergen (US), OMEGA Engineering Inc. (US), DeltaTrak Inc. (US), Beurer GmbH (Germany), Nureca (India), iHealth Labs Inc. (US), Kinsa INC. (US), and medisana GmbH (Germany).

Research Coverage

This report studies the patient temperature monitoring market based on product, site, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights on the following pointers:

• Analysis of Key drivers (increasing prevalence of infectious diseases, growing awareness about continuous temperature monitoring for surgical patients, rising volume of surgical interventions, increased adoption of remote patient monitoring in home healthcare settings),
• challenge (elevated costs of advanced temperature monitoring systems in emerging economies, risks associated with invasive temperature monitoring devices), opportunity (increasing growth opportunities in emerging markets, increased focus on better healthcare infrastructure and digital health initiatives in emerging economies, integration of predictive analytics in vital sign monitoring systems, rising need for blood transfusions among chronic patients), challenges (limited accuracy and reliability in infrared and traditional mercury thermometers, incorporation of inorganic growth strategies among key players)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the patient temperature monitoring market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product approvals in the patient temperature monitoring market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the patient temperature monitoring market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key sources for secondary data
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Key objectives of primary research
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Key industry insights
    • 2.1.2.5 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
      • 2.2.1.1.1 Presentations of companies and primary interviews
      • 2.2.1.1.2 Primary interviews
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 DATA TRIANGULATION
• 2.4 MARKET SHARE ANALYSIS
• 2.5 STUDY ASSUMPTIONS
  • 2.5.1 PARAMETRIC ASSUMPTIONS
  • 2.5.2 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PATIENT TEMPERATURE MONITORING MARKET OVERVIEW
• 4.2 ASIA PACIFIC: PATIENT TEMPERATURE MONITORING MARKET, BY PRODUCT AND COUNTRY
• 4.3 PATIENT TEMPERATURE MONITORING MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
• 4.4 PATIENT TEMPERATURE MONITORING MARKET: REGIONAL MIX, 2025 VS. 2032
• 4.5 PATIENT TEMPERATURE MONITORING MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing prevalence of infectious diseases
    • 5.2.1.2 Growing awareness about continuous temperature monitoring for surgical patients
    • 5.2.1.3 Rising volume of surgical interventions
    • 5.2.1.4 Increased adoption of remote patient monitoring in home healthcare settings
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Elevated costs of advanced temperature monitoring systems in emerging economies
    • 5.2.2.2 Risks associated with invasive temperature monitoring devices
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing growth opportunities in emerging markets
    • 5.2.3.2 Increased focus on better healthcare infrastructure and digital health initiatives in emerging economies
    • 5.2.3.3 Integration of predictive analytics in vital sign monitoring systems
    • 5.2.3.4 Rising need for blood transfusions among chronic patients
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limited accuracy and reliability in infrared and traditional mercury thermometers
    • 5.2.4.2 Incorporation of inorganic growth strategies among key players
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Sensor technologies
    • 5.3.1.2 Digital thermometry and wearables
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Electronic health records
    • 5.3.2.2 Remote patient monitoring platforms
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 Multi-parameter wearable biosensors
• 5.4 PORTER'S FIVE FORCES ANALYSIS
  • 5.4.1 BARGAINING POWER OF BUYERS
  • 5.4.2 BARGAINING POWER OF SUPPLIERS
  • 5.4.3 THREAT OF NEW ENTRANTS
  • 5.4.4 THREAT OF SUBSTITUTES
  • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.5 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.5.2 KEY BUYING CRITERIA
• 5.6 REGULATORY ANALYSIS
  • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.6.2 REGULATORY FRAMEWORK
    • 5.6.2.1 North America
      • 5.6.2.1.1 US
      • 5.6.2.1.2 Canada
    • 5.6.2.2 Europe
    • 5.6.2.3 Asia Pacific
      • 5.6.2.3.1 China
      • 5.6.2.3.2 Japan
      • 5.6.2.3.3 India
    • 5.6.2.4 Latin America
      • 5.6.2.4.1 Brazil
      • 5.6.2.4.2 Mexico
    • 5.6.2.5 Middle East
    • 5.6.2.6 Africa
• 5.7 PATENT ANALYSIS
  • 5.7.1 LIST OF MAJOR PATENTS
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT DATA FOR HS CODE 902511, 2020-2024
  • 5.8.2 EXPORT DATA FOR HS CODE 902511, 2020-2024
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE TREND OF PATIENT TEMPERATURE MONITORING DEVICES, BY KEY PLAYER, 2022-2024
  • 5.9.2 AVERAGE SELLING PRICE TREND OF PATIENT TEMPERATURE MONITORING DEVICES, BY REGION, 2022-2024
• 5.10 REIMBURSEMENT ANALYSIS
  • 5.10.1 NORTH AMERICA
    • 5.10.1.1 US
      • 5.10.1.1.1 Medicare reimbursement for remote patient monitoring
  • 5.10.2 EUROPE
  • 5.10.3 ASIA PACIFIC
  • 5.10.4 GLOBAL CONSIDERATIONS
• 5.11 KEY CONFERENCES & EVENTS, 2025-2026
• 5.12 UNMET NEEDS/END-USER EXPECTATIONS
• 5.13 VALUE CHAIN ANALYSIS
• 5.14 SUPPLY CHAIN ANALYSIS
• 5.15 IMPACT OF AI/GEN AI ON PATIENT TEMPERATURE MONITORING MARKET
  • 5.15.1 MARKET POTENTIAL OF AI/GEN AI
  • 5.15.2 KEY AI USE CASES
  • 5.15.3 FUTURE OF AI/GEN AI
• 5.16 IMPACT OF 2025 US TARIFF REGULATION ON PATIENT TEMPERATURE MONITORING MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 KEY TARIFF RATES
  • 5.16.3 PRICE IMPACT ANALYSIS
  • 5.16.4 KEY IMPACTS ON COUNTRY/REGION
    • 5.16.4.1 North America
      • 5.16.4.1.1 US
    • 5.16.4.2 Europe
    • 5.16.4.3 Asia Pacific
  • 5.16.5 IMPACT ON END-USE INDUSTRIES
    • 5.16.5.1 Hospitals
    • 5.16.5.2 Ambulatory care centers
• 5.17 ECOSYSTEM ANALYSIS
  • 5.17.1 ROLE IN ECOSYSTEM
• 5.18 CASE STUDY ANALYSIS
  • 5.18.1 ESVYDA'S REMOTE PATIENT MONITORING SYSTEM TO ENHANCE CHRONIC CARE THROUGH TEMPERATURE AND VITAL SIGN TRACKING
• 5.19 ADJACENT MARKET ANALYSIS
• 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.21 INVESTMENT & FUNDING SCENARIO

6 PATIENT TEMPERATURE MONITORING MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 WEARABLE CONTINUOUS MONITORING SENSORS
  • 6.2.1 INCREASED PREFERENCE FOR PORTABLE TEMPERATURE MONITORING DEVICES TO AID MARKET GROWTH
• 6.3 SMART TEMPERATURE MONITORING PATCHES
  • 6.3.1 NEED FOR CONTINUOUS HEALTH STATUS MONITORING OF INFANTS, ELDERLY, AND POST-OPERATIVE PATIENTS TO DRIVE MARKET
• 6.4 TABLETOP TEMPERATURE MONITORING DEVICES
  • 6.4.1 NON-INVASIVE VITAL SIGNS MONITORING DEVICES
    • 6.4.1.1 High demand for automatic, rapid, and routine measurement and documentation of vital signs to aid adoption in hospital settings
  • 6.4.2 CONTINUOUS CORE BODY TEMPERATURE MONITORING DEVICES
    • 6.4.2.1 Increasing incidence of cardiac arrest, head injury, and stroke to propel need for core body temperature monitoring
• 6.5 HANDHELD TEMPERATURE MONITORING DEVICES
  • 6.5.1 DIGITAL THERMOMETERS
    • 6.5.1.1 Better accuracy, easy portability, and improved user interface to spur segment growth
  • 6.5.2 INFRARED THERMOMETERS
    • 6.5.2.1 Faster response time for surface temperature and minimal risk of contamination to aid adoption in infection-sensitive cases
  • 6.5.3 MERCURY THERMOMETERS
    • 6.5.3.1 Lack of accuracy, high maintenance, and slow response time to limit market adoption
• 6.6 INVASIVE TEMPERATURE MONITORING DEVICES
  • 6.6.1 RISING PREVALENCE OF BLOODSTREAM INFECTIONS TO RESTRICT ADOPTION

7 PATIENT TEMPERATURE MONITORING MARKET, BY SITE

• 7.1 INTRODUCTION
• 7.2 NON-INVASIVE TEMPERATURE MONITORING
  • 7.2.1 ORAL TEMPERATURE MONITORING
    • 7.2.1.1 Cost-effectiveness and broad use in general wards to support segment growth
  • 7.2.2 AXILLARY & TEMPORAL ARTERY TEMPERATURE MONITORING
    • 7.2.2.1 Ease of use, non-invasiveness, and better comfort to drive adoption in pediatric, geriatric, and home care applications
  • 7.2.3 TYMPANIC MEMBRANE TEMPERATURE MONITORING
    • 7.2.3.1 High accuracy in core body temperature measurement to facilitate adoption in ambulatory care settings
• 7.3 INVASIVE TEMPERATURE MONITORING
  • 7.3.1 ESOPHAGEAL TEMPERATURE MONITORING
    • 7.3.1.1 Higher level of accuracy and lower chances of dislocation to drive adoption among anesthetized patients in ICU settings
  • 7.3.2 NASOPHARYNX TEMPERATURE MONITORING
    • 7.3.2.1 Rising risk of epistaxis and sinusitis to hinder market growth
  • 7.3.3 URINARY BLADDER TEMPERATURE MONITORING
    • 7.3.3.1 Low risk of dislocation of temperature probes to boost market growth
  • 7.3.4 RECTAL TEMPERATURE MONITORING
    • 7.3.4.1 Enhanced core temperature accuracy for neonatal and critical care to fuel segment expansion

8 PATIENT TEMPERATURE MONITORING MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 PYREXIA/FEVER
  • 8.2.1 RISING PREVALENCE OF INFECTIOUS DISEASES AND FEBRILE ILLNESSES TO BOOST SEGMENT GROWTH
• 8.3 HYPOTHERMIA
  • 8.3.1 INCREASING SURGICAL PROCEDURES TO FUEL NEED FOR BETTER TEMPERATURE MONITORING
• 8.4 ANESTHESIA
  • 8.4.1 RISING MORTALITY RATE DUE TO MALIGNANT HYPERPYREXIA TO DRIVE MARKET
• 8.5 BLOOD TRANSFUSION
  • 8.5.1 EMPHASIS ON BLOOD TRANSFUSION SAFETY TO DRIVE ADOPTION OF ADVANCED TEMPERATURE MONITORING DEVICES
• 8.6 OTHER APPLICATIONS

9 PATIENT TEMPERATURE MONITORING MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS
  • 9.2.1 INTENSIVE CARE UNITS
    • 9.2.1.1 Increasing cases of thermoregulation disruption to drive adoption of advanced temperature monitoring devices
  • 9.2.2 OPERATING ROOMS
    • 9.2.2.1 Necessity of managing intraoperative hypothermia to augment segment growth
  • 9.2.3 EMERGENCY ROOMS
    • 9.2.3.1 High patient turnover to accelerate demand for rapid and reliable temperature monitoring
• 9.3 HOME CARE SETTINGS
  • 9.3.1 RISE IN GLOBAL GERIATRIC AND PEDIATRIC POPULATION TO FUEL MARKET GROWTH
• 9.4 AMBULATORY CARE CENTERS
  • 9.4.1 EASE OF DIAGNOSIS, RAPID RESULT GENERATION, AND IMMEDIATE PATIENT CARE MANAGEMENT TO AID MARKET GROWTH
• 9.5 URGENT CARE CENTERS
  • 9.5.1 NEED FOR RAPID CLINICAL ASSESSMENT TO AUGMENT ADOPTION OF ACCURATE TEMPERATURE ASSESSMENT TOOLS
• 9.6 PRIMARY CENTERS
  • 9.6.1 INTEGRATION OF PATIENT TEMPERATURE MONITORING TO SUPPORT TIMELY DIAGNOSIS AND CARE CONTINUITY
• 9.7 OTHER END USERS

10 PATIENT TEMPERATURE MONITORING MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American patient temperature monitoring market during study period
  • 10.2.3 CANADA
    • 10.2.3.1 Growing incidence of chronic diseases and increasing surgical procedures to drive market demand
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 High demand for temperature monitoring devices for perioperative care to propel market growth
  • 10.3.3 UK
    • 10.3.3.1 Rising interventional chronic procedures among geriatric patients to support market growth
  • 10.3.4 FRANCE
    • 10.3.4.1 Rising chronic diseases among geriatric and pediatric populations to spur market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Increase in per capita health spending and occurrence of health complications among geriatric patients to drive market
  • 10.3.6 SPAIN
    • 10.3.6.1 Healthcare modernization and chronic disease management to aid adoption of patient temperature monitoring devices
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Surge in surgical volume and favorable healthcare reforms to fuel market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Increasing funds for healthcare infrastructure improvement to fuel market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Developing healthcare infrastructure and increasing C-section surgeries to augment market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Increased government healthcare investments to support market adoption of advanced patient temperature monitoring devices
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 High geriatric population to drive demand for advanced patient temperature monitoring solutions for chronic conditions
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Rising volume of surgeries in tertiary care centers to drive adoption of advanced temperature monitoring devices
  • 10.5.3 MEXICO
    • 10.5.3.1 Favorable government initiatives and integration of digital health technologies to propel market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Kingdom of Saudi Arabia
      • 10.6.2.1.1 Rapid healthcare digitization to accelerate market expansion
    • 10.6.2.2 UAE
      • 10.6.2.2.1 Growing medical tourism and technological advancements to augment market growth
    • 10.6.2.3 Rest of GCC Countries
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT TEMPERATURE MONITORING MARKET
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY VALUATION & FINANCIAL METRICS
  • 11.5.1 FINANCIAL METRICS
  • 11.5.2 COMPANY VALUATION
• 11.6 BRAND/PRODUCT COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Site footprint
    • 11.7.5.4 Product footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.8.5.1 Detailed list of key startup/SME players
    • 11.8.5.2 Competitive benchmarking of key startups/SME players
• 11.9 R&D ASSESSMENT OF KEY PLAYERS
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT APPROVALS
  • 11.10.2 DEALS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 KONINKLIJKE PHILIPS N.V.
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 CARDINAL HEALTH
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 MnM view
      • 12.1.2.3.1 Key strengths
      • 12.1.2.3.2 Strategic choices
      • 12.1.2.3.3 Weaknesses & competitive threats
  • 12.1.3 BAXTER (HILL-ROM HOLDINGS, INC.)
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 MnM view
      • 12.1.3.3.1 Key strengths
      • 12.1.3.3.2 Strategic choices
      • 12.1.3.3.3 Weaknesses & competitive threats
  • 12.1.4 DRAGERWERK AG & CO. KGAA
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 MnM view
      • 12.1.4.3.1 Key strengths
      • 12.1.4.3.2 Strategic choices
      • 12.1.4.3.3 Weaknesses & competitive threats
  • 12.1.5 HELEN OF TROY
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 MnM view
      • 12.1.5.3.1 Key strengths
      • 12.1.5.3.2 Strategic choices
      • 12.1.5.3.3 Weaknesses & competitive threats
  • 12.1.6 BECTON, DICKINSON AND COMPANY
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
  • 12.1.7 OMRON HEALTHCARE, INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
  • 12.1.8 MASIMO
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product approvals
      • 12.1.8.3.2 Deals
  • 12.1.9 SOLVENTUM
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
  • 12.1.10 TERUMO CORPORATION
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 PAUL HARTMANN AG
  • 12.2.2 BEURER GMBH
  • 12.2.3 MICROLIFE CORPORATION
  • 12.2.4 OMEGA ENGINEERING INC.
  • 12.2.5 IHEALTH LABS INC.
  • 12.2.6 DELTATRAK INC.
  • 12.2.7 EXERGEN
  • 12.2.8 MEDISANA GMBH
  • 12.2.9 GERATHERM MEDICAL AG
  • 12.2.10 AMERICAN DIAGNOSTIC CORPORATION
  • 12.2.11 NURECA
  • 12.2.12 A&D COMPANY, LIMITED
  • 12.2.13 MEDTRONIC
  • 12.2.14 DONGGUAN ACTHERM MEDICAL CORP.
  • 12.2.15 COSINUSS GMBH
  • 12.2.16 KINSA INC.
  • 12.2.17 EASYTEM
  • 12.2.18 HICKS INDIA
  • 12.2.19 THERMOMEDICS, INC.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS